Posted in | News | Nanobusiness

DRI Capital Acquires Royalties from Nanogen for US$10 Million

DRI Capital Inc and Nanogen, Inc announced today that they have entered into an agreement for DRI to acquire, for US$10 million, all future royalties generated by Applied Biosystems (ABI) under a license ABI has taken from Nanogen for MGB(TM) (minor groove binder) technology.

"This transaction extends DRI's interests in royalties related to molecular biology research tools," said Joshua Salisbury, Managing Director at DRI. "This agreement is another example of the tailored and innovative sources of capital DRI offers and we are pleased that we were able to work with Nanogen again."

"Monetizing this royalty stream provides us with a non-dilutive means of raising capital to fund our operations as we work towards achieving cash flow breakeven in late 2008," said Howard C. Birndorf, Nanogen chairman and chief executive officer.

The royalty payments included in the agreement are related to Nanogen's patented MGB(TM) technology that has been licensed to ABI for use in ABI's TaqMan(R) products (TaqMan(R) is a registered trademark of Roche Molecular Systems, Inc.). ABI's TaqMan(R) assays library using Nanogen's MGB(TM) is the leading life science research product library for PCR applications. Nanogen's MGB(TM) technology provides many advantages in the design of oligonucleotide probes, and has become a sought after component for many companies working in the molecular detection and diagnostic marketplace. Nanogen has an active partnering and licensing program and has more than 40 patents related to nucleic acid detection.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Nanogen. (2019, February 15). DRI Capital Acquires Royalties from Nanogen for US$10 Million. AZoNano. Retrieved on October 13, 2024 from https://www.azonano.com/news.aspx?newsID=6182.

  • MLA

    Nanogen. "DRI Capital Acquires Royalties from Nanogen for US$10 Million". AZoNano. 13 October 2024. <https://www.azonano.com/news.aspx?newsID=6182>.

  • Chicago

    Nanogen. "DRI Capital Acquires Royalties from Nanogen for US$10 Million". AZoNano. https://www.azonano.com/news.aspx?newsID=6182. (accessed October 13, 2024).

  • Harvard

    Nanogen. 2019. DRI Capital Acquires Royalties from Nanogen for US$10 Million. AZoNano, viewed 13 October 2024, https://www.azonano.com/news.aspx?newsID=6182.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.